{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:00:24Z","timestamp":1785074424896,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118169","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:47:29Z","timestamp":1781711249000},"page":"118169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["G22037, a novel oxadiazole-pyrazole derivative, attenuates liver fibrosis by targeting annexin A5 and inhibition of ER stress-dependent hepatic stellate cell activation"],"prefix":"10.1016","volume":"251","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changbin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2836-2885","authenticated-orcid":false,"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2026.118169_b0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/15321810701454649","article-title":"Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C","volume":"28","author":"Attallah","year":"2007","journal-title":"J. Immunoassay Immunochem."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.118169_b0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-5793(93)81507-V","article-title":"Calcium influx through annexin V ion channels into large unilamellar vesicles measured with fura-2","volume":"317","author":"Berendes","year":"1993","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.bcp.2026.118169_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ph18091321","article-title":"Present and Future Perspectives in the Treatment of Liver Fibrosis","volume":"18","author":"Cerrito","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"10.1016\/j.bcp.2026.118169_b0020","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/liv.14940","article-title":"Hepatic macrophages: Key players in the development and progression of liver fibrosis","volume":"41","author":"Cheng","year":"2021","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.bcp.2026.118169_b0025","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","article-title":"Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment","volume":"305","author":"Clapper","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118169_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0328493","article-title":"Liver cirrhosis in 2021: Global Burden of Disease study","volume":"20","author":"Duo","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118169_b0035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","article-title":"Calcium and ROS: a mutual interplay","volume":"6","author":"Gorlach","year":"2015","journal-title":"Redox Biol."},{"issue":"10213","key":"10.1016\/j.bcp.2026.118169_b0040","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcp.2026.118169_b0045","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bcp.2026.118169_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052865","article-title":"The Relevance, Predictability, and Utility of Annexin A5 for Human Physiopathology","volume":"25","author":"Jing","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2026.118169_b0055","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1248\/bpb.b22-00103","article-title":"Ca(2+) Signaling and Proliferation via Ca(2+)-Sensing Receptors in Human Hepatic Stellate LX-2 Cells","volume":"45","author":"Kondo","year":"2022","journal-title":"Biol. Pharm. Bull."},{"issue":"23","key":"10.1016\/j.bcp.2026.118169_b0060","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0960-9822(00)80085-8","article-title":"Annexin 5 mediates a peroxide-induced Ca(2+) influx in B cells","volume":"9","author":"Kubista","year":"1999","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118169_b0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4062\/biomolther.2013.026","article-title":"Annexin a5 as a new potential biomarker for Cisplatin-induced toxicity in human kidney epithelial cells","volume":"21","author":"Kwon","year":"2013","journal-title":"Biomol Ther (seoul)"},{"key":"10.1016\/j.bcp.2026.118169_b0070","doi-asserted-by":"crossref","first-page":"15429","DOI":"10.2147\/JIR.S532042","article-title":"Glycochenodeoxycholic acid induces the release of IL-1beta from L02 cells via the NLRP3\/caspase-1\/GSDMD pathway to activate LX2 cells","volume":"18","author":"Li","year":"2025","journal-title":"J. Inflamm. Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118169_b0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Mederacke","year":"2015","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.bcp.2026.118169_b0080","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118169_b0085","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/s44318-025-00454-9","article-title":"Annexin A5 controls VDAC1-dependent mitochondrial Ca(2+) homeostasis and determines cellular susceptibility to apoptosis","volume":"44","author":"Oflaz","year":"2025","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bcp.2026.118169_b0090","doi-asserted-by":"crossref","first-page":"19648","DOI":"10.1038\/s41598-024-69764-y","article-title":"NLRP3 inflammasome pathway involved in the pathogenesis of metabolic associated fatty liver disease","volume":"14","author":"Osman","year":"2024","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.bcp.2026.118169_b0095","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis","volume":"392","author":"Sanyal, A. J., Newsome, P. N., Kliers, I., Ostergaard, L. H., Long, M. T., Kjaer, M. S., Group, E. S","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118169_b0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","article-title":"Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly","volume":"31","author":"Simon","year":"2020","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bcp.2026.118169_b0105","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/j.gastro.2007.05.027","article-title":"Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice","volume":"133","author":"Teoh","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bcp.2026.118169_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010163","article-title":"All you can Feed: some comments on production of Mouse Diets used in Biomedical Research with special Emphasis on Non-Alcoholic Fatty Liver Disease Research","volume":"12","author":"Weiskirchen","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.118169_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/jimr\/2656395","article-title":"Immune System and Hepatic Stellate Cells' Crosstalk in Liver Fibrosis: Pathways and Therapeutic potential","volume":"2026","author":"Widowati","year":"2026","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118169_b0120","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2026.118169_b0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118169_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.168062","article-title":"Interactions between hepatic stellate cells and immune cells: Implications for liver fibrosis","volume":"1872","author":"Xie","year":"2026","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bcp.2026.118169_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101634","article-title":"Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH","volume":"36","author":"Xu","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2026.118169_b0140","doi-asserted-by":"crossref","DOI":"10.3791\/56930","article-title":"Partial Bile Duct Ligation in the Mouse: a Controlled Model of Localized Obstructive Cholestasis","author":"Yokota","year":"2018","journal-title":"J vis Exp(133)"},{"key":"10.1016\/j.bcp.2026.118169_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114864","article-title":"New insights into therapeutic strategies for targeting hepatic macrophages to alleviate liver fibrosis","volume":"158","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118169_b0150","doi-asserted-by":"crossref","DOI":"10.1093\/stmcls\/sxaf072","article-title":"Macrophage heterogeneity and plasticity in liver injury and repair mechanisms","volume":"44","author":"Zhang","year":"2026","journal-title":"Stem Cells"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:14:22Z","timestamp":1785071662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0006295226005071"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118169","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"G22037, a novel oxadiazole-pyrazole derivative, attenuates liver fibrosis by targeting annexin A5 and inhibition of ER stress-dependent hepatic stellate cell activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118169"}}